Brinton Pharmaceuticals Limited

Pharmaceutical company manufacturing and trading various therapeutic products with certified manufacturing partners.

2013 | Pune, Maharashtra (India) | Active
Last Updated: December 15, 2024

Brinton Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.09 Cr
  • Company Age 11 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 47.75 Cr
  • Satisfied Charges ₹ 35.00 Cr
  • Revenue Growth 13.33%
  • Profit Growth 160.49%
  • Ebitda 111.29%
  • Net Worth 54.08%
  • Total Assets 42.39%

About Brinton Pharmaceuticals

Brinton Pharmaceuticals Limited (BPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 27 September 2013 and has a history of 11 years and four months. Its registered office is in Pune, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.09 Cr.

The company currently has active open charges totaling ₹47.75 Cr. The company has closed loans amounting to ₹35.00 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Brinton Pharmaceuticals Limited India are Chandra Singh as CFO and Neha Pandya as Company Secretary. Rahul Darda, Shivani Bhasin, Vijey Victor, and Four other members serve as directors at the Company.

Company Details

  • Location

    Pune, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    brintonhealth.com

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232PN2013PLC148971

  • Company No.

    148971

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    27 Sep 2013

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Pune

Industry

Pharma

What products or services does Brinton Pharmaceuticals Limited offer?

Brinton Pharmaceuticals Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiviral Drugs, Face Mask & Medical PPE Kits, Personal Protective Equipment, Skin Care, Bath Essentials, Hair Care, Hair Growth for Men, Facewash, Sunscreen Products.

Who are the key members and board of directors at Brinton Pharmaceuticals?

Executive Team (3)

NameDesignationAppointment DateStatus
Rahul Darda Country flag representing In Managing Director27-Sep-2013Current
Chandra Singh CFO25-Oct-2019Current
Neha Pandya Company Secretary10-Apr-2024Current

Board Members (6)

NameDesignationAppointment DateStatus
Vijey Victor Country flag representing In Director 30-Sep-2017Current
Shivani Bhasin Country flag representing In Nominee Director 13-Jun-2019Current
Chaitali Darda Country flag representing In Director 27-Sep-2013Current
Visalakshi Chandramouli Country flag representing In Nominee Director 30-Mar-2017Current
Sudeep Chhallani Country flag representing In Director 28-Mar-2024Current
Ronak Shah Country flag representing In Director 28-Mar-2024Current

Financial Performance of Brinton Pharmaceuticals.

Brinton Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.33% increase. The company also saw a substantial improvement in profitability, with a 160.49% increase in profit. The company's net worth Soared by an impressive increase of 54.08%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
13.33%
Revenue from Operations
12.63%
Total Assets
42.39%
Profit or Loss
160.49%
Net Worth
54.08%
EBITDA
111.29%

What is the Ownership and Shareholding Structure of Brinton Pharmaceuticals?

In 2021, Brinton Pharmaceuticals had a promoter holding of 87.84% and a public holding of 12.15%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹47.75 Cr

Satisfied Charges

₹35.00 Cr

Charges Breakdown by Lending Institutions

  • Others : 47.75 Cr

Latest Charge Details

DateLenderAmountStatus
04 Sep 2024Others₹4.00 CrOpen
27 Jun 2023Others₹7.50 CrOpen
09 Jun 2023Others₹3.00 CrOpen
31 Jan 2023Others₹16.00 CrOpen
30 Aug 2021Others₹17.00 CrOpen

How Many Employees Work at Brinton Pharmaceuticals?

Brinton Pharmaceuticals has a workforce of 508 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Brinton Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brinton Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Brinton Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Brinton Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Charges

    A charge with Others amounted to Rs. 4.00 Cr with Charge ID 100974582 was registered on 04 Sep 2024.

    04 Sep 2024

  • Charges

    A charge with Others of Rs. 7.50 Cr registered on 27 Jun 2023 with Charge ID 100750207 was modified on 29 Jul 2024.

    29 Jul 2024

  • Director Appointment

    Neha Amrutlal Pandya was appointed as a Company Secretary was appointed as a Company Secretary on 10 Apr 2024 & has been associated with this company since 10 months 13 days .

    10 Apr 2024

  • Balance Sheet

    Brinton Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.

    31 Mar 2024

  • Charges

    A charge with Others of Rs. 17.00 Cr registered on 30 Aug 2021 with Charge ID 100514652 was modified on 30 Mar 2024.

    30 Mar 2024

Recent News, Updates & Announcement

Frequently asked questions

  • Brinton Pharmaceuticals Limited was incorporated on 27 Sep 2013.

  • The authorized share capital of Brinton Pharmaceuticals Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.09 Cr.

  • Currently 9 directors are associated with Brinton Pharmaceuticals Limited.

    • Rahul Kundanmal Darda
    • Shivani Bhasin
    • Vijey Christopher James Victor
    • Chaitali Rahul Darda
    • Visalakshi Chandramouli
    • Sudeep Chhallani
    • Ronak Hemprakash Shah
    • Chandra Prakash Singh
    • Neha Amrutlal Pandya
  • As per Ministry of Corporate Affairs (Mca), the registered address of Brinton Pharmaceuticals Limited is S. No 55/2 Kharadi, Taluka Haveli India, Pune, Maharashtra, 411014.

  • The corporate identification number (CIN) of Brinton Pharmaceuticals Limited is U24232PN2013PLC148971 and the company number is 148971 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Brinton Pharmaceuticals Limited is https://www.brintonhealth.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Brinton Pharmaceuticals Limited has risen by 13.33%.

  • As Per 2022 financial reports, 508 employees are currently employed by Brinton Pharmaceuticals Limited.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Brinton Pharmaceuticals Limited has experienced an upsurge of 54.08%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Brinton Pharmaceuticals Limited amount to ₹ 47.75 Cr.

  • The most recent Balance Sheet for Brinton Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development